The Prevalence of Phenylketonuria in Arab Countries, Turkey, and Iran: A Systematic Review
Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
Published on: June 23, 2023
Ashraf El-Metwally1,2, Lujane Yousef Al-Ahaidib3, Alaa Ayman Sunqurah1
1King Abdullah International Medical Research Center (KAIMRC) and College of Public Health and Health Informatics, King Saud Bin AbdulAziz University for Health Sciences, Riyadh, Saudi Arabia.
Insights
Phenylketonuria (PKU) prevalence in Arab countries, Turkey, and Iran varies, with Turkey reporting the highest rate (0.0167%) and UAE the lowest (0.005%). This highlights the need for improved PKU screening and reporting systems in the region.
Area of Science:
- Medical Genetics
- Public Health
- Pediatrics
Background:
- Phenylketonuria (PKU) is a rare genetic disorder.
- Consanguinity is a known risk factor for recessive genetic disorders.
- Newborn screening programs are crucial for early detection and management of PKU.
Purpose of the Study:
- To determine the prevalence of Phenylketonuria (PKU) in Arab countries, Turkey, and Iran.
- To assess the availability and comprehensiveness of national newborn screening programs for PKU in these regions.
- To review reported consanguinity rates in relation to PKU prevalence.
Main Methods:
- A comprehensive literature search was performed using relevant keywords to identify studies on PKU.
- A total of 34 articles were included in the review.
- PKU prevalence data was categorized based on the diagnostic screening methods employed.
Main Results:
- The prevalence of classical PKU, identified through national newborn screening, ranged from 0.005% to 0.0167%.
- Turkey reported the highest PKU prevalence at 0.0167%.
- The United Arab Emirates (UAE) showed the lowest prevalence at 0.005%.
Conclusions:
- The study underscores the necessity for enhanced reporting systems in the studied countries.
- Improved systems are needed to accurately measure Disability-Adjusted Life Year (DALY).
- Estimating the societal burden of PKU requires robust data collection and analysis.
Background/Objectives:
This paper seeks to identify the prevalence of Phenylketonuria (PKU) in Arab countries, Turkey, and Iran. The study reviewed the existence of comprehensive national newborn screening programs and reported consanguinity rates.
Methods:
A computer based literature search was conducted using relevant keywords to retrieve studies conducted on PKU. A total of 34 articles were included. Prevalence was categorized based on the type of screening method used for PKU diagnoses.
Results:
The prevalence of classical PKU diagnosed through a comprehensive national newborn screening program ranged from 0.005% to 0.0167%. The highest prevalence was reported in Turkey at 0.0167%, whereas the lowest prevalence was reported in the UAE, 0.005%.
Conclusion:
The findings of this review emphasize the need for the establishment of more efficient reporting systems in these countries that would help measure Disability-Adjusted Life Year (DALY) in order to estimate the overall societal burden of PKU.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Propagation of Uncertainty from Systematic Error

